Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Dec 15, 2021 23:04 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 200 | $124.18 | $24,835.00 |
DisclosureSEC source: 0001062993-21-012954 · form4.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,837 Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 23:04 UTC |
Yi SangPresident, Asia Pacific
|
SaleCommon Stock | 2,600 | $124.14 | $322,764.00 |
DisclosureSEC source: 0001062993-21-012954 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,037 F1 · balance_after: Includes 96 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · derivative · entry 9 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,524 Underlying: Common Stock · 1,524 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2021. The remaining RSUs vest on December 3, 2022. F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2021. The remaining RSUs vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 925 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · derivative · entry 8 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925 Underlying: Common Stock · 925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2021. The remaining RSUs vest on December 3, 2022. F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2021. The remaining RSUs vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · derivative · entry 7 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,089 Underlying: Common Stock · 1,089 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2021. The remaining RSUs vest on December 3, 2022. F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2021. The remaining RSUs vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Tax withholdingCommon Stock | 875 | $121.98 | $106,732.50 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · nonDerivative · entry 6 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,005 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Exercise / conversionCommon Stock | 1,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · nonDerivative · entry 5 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Tax withholdingCommon Stock | 531 | $121.98 | $64,771.38 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · nonDerivative · entry 4 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,356 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Exercise / conversionCommon Stock | 925 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · nonDerivative · entry 3 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Tax withholdingCommon Stock | 625 | $121.98 | $76,237.50 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,962 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:15 UTC |
Tornos IvanChief Operating Officer
|
Exercise / conversionCommon Stock | 1,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012318 · form4.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 96 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 22:03 UTC |
Nichol Carrie AnnVP, Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-009219 · form4.xml · derivative · entry 3 Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327 Underlying: Common Stock · 164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: 164 RSUs vested on each of October 1, 2020 and October 1, 2021. Half of the remaining 327 RSUs vest on each of October 1, 2022 and October 1, 2023. F4 · derivative.expiration_date: 164 RSUs vested on each of October 1, 2020 and October 1, 2021. Half of the remaining 327 RSUs vest on each of October 1, 2022 and October 1, 2023. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 22:03 UTC |
Nichol Carrie AnnVP, Controller & CAO
|
Tax withholdingCommon Stock | 52 | $148.57 | $7,725.64 |
DisclosureSEC source: 0001062993-21-009219 · form4.xml · nonDerivative · entry 2 Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 22:03 UTC |
Nichol Carrie AnnVP, Controller & CAO
|
Exercise / conversionCommon Stock | 164 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-009219 · form4.xml · nonDerivative · entry 1 Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 114 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between December 31, 2020 and June 30, 2021. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:22 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 185.347 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009212 · form4.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,504.511 Underlying: Common Stock · 185.347 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 11.929 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:20 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 92.674 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009209 · form4.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763.866 Underlying: Common Stock · 92.674 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.858 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:18 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 92.674 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009207 · form4.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813.663 Underlying: Common Stock · 92.674 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 3.858 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:17 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 185.347 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009205 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,115.008 Underlying: Common Stock · 185.347 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 92.674 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 92.674 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 5.503 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:14 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 219.047 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009203 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,150.105 Underlying: Common Stock · 219.047 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 39.13 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:13 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 227.471 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009201 · form4.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,552.032 Underlying: Common Stock · 227.471 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 32.375 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:10 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 210.622 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009197 · form4.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,506.747 Underlying: Common Stock · 210.622 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 13.325 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:09 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 252.746 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009195 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,590.426 Underlying: Common Stock · 252.746 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 19.15 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:07 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 210.622 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009193 · form4.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,743.234 Underlying: Common Stock · 210.622 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 20.991 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 19:25 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,655 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-006235 · form4.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,310 Underlying: Common Stock · 3,655 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: The RSUs vest as follows: 3,655 vested on each of July 1, 2020 and July 1, 2021; and of the remaining 7,310 RSUs, 3,655 are scheduled to vest on each of July 1, 2022 and July 1, 2023. F4 · derivative.expiration_date: The RSUs vest as follows: 3,655 vested on each of July 1, 2020 and July 1, 2021; and of the remaining 7,310 RSUs, 3,655 are scheduled to vest on each of July 1, 2022 and July 1, 2023. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 19:25 UTC |
Upadhyay SuketuExec. VP, CFO
|
Tax withholdingCommon Stock | 1,112 | $161.94 | $180,077.28 |
DisclosureSEC source: 0001062993-21-006235 · form4.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,304 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 19:25 UTC |
Upadhyay SuketuExec. VP, CFO
|
Exercise / conversionCommon Stock | 3,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-006235 · form4.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between July 9, 2020 and January 9, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:35 UTC |
VAN ZUILEN WILFREDPres, Europe, M. East & Africa
|
GrantRestricted Stock Units · Derivative | 10,215 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-006359 · form4.xml · derivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Pres, Europe, M. East & Africa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,215 Underlying: Common Stock · 10,215 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock. F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2022. F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2022. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:35 UTC |
VAN ZUILEN WILFREDPres, Europe, M. East & Africa
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,208 | $0.00 Strike: $161.94 | $0.00 |
DisclosureSEC source: 0001062993-21-006359 · form4.xml · derivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Pres, Europe, M. East & Africa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,208 Underlying: Common Stock · 40,208 shares Expires 2031-07-01 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2022. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:41 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 170.882 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006286 · form4.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,307.235 Underlying: Common Stock · 170.882 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:40 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 85.441 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006283 · form4.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,717.131 Underlying: Common Stock · 85.441 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:41 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 85.441 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006284 · form4.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670.334 Underlying: Common Stock · 85.441 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:40 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 201.951 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006281 · form4.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,891.928 Underlying: Common Stock · 201.951 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:40 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 170.882 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006282 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,924.158 Underlying: Common Stock · 170.882 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 85.441 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 85.441 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:39 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 194.184 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006279 · form4.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,282.8 Underlying: Common Stock · 194.184 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:39 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 209.719 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006280 · form4.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,292.186 Underlying: Common Stock · 209.719 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:38 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 256.323 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006277 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,318.53 Underlying: Common Stock · 256.323 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:38 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 194.184 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006278 · form4.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,511.621 Underlying: Common Stock · 194.184 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 20, 2021 Filed Jul 2, 2021 20:40 UTC |
HIGGINS ARTHUR JDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-006281 · form4.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:06 UTC |
MICHELSON MICHAEL WDirector
|
GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004829 · form4.xml · derivative · entry 2 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,273.491 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:06 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004829 · form4.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,136.353 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 10.095 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:05 UTC |
Kolli SreelakshmiDirector
|
GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004828 · form4.xml · derivative · entry 2 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779.05 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:05 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004828 · form4.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584.893 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:05 UTC |
Jafry Syed A.Director
|
GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004827 · form4.xml · derivative · entry 2 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934.401 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:05 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004827 · form4.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,631.69 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 2.767 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:05 UTC |
Hilado Maria TeresaDirector
|
GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004826 · form4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934.401 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:05 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004826 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,753.276 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 4.169 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:04 UTC |
HIGGINS ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004825 · form4.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,696.86 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:04 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004825 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,689.977 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 35.139 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:04 UTC |
HAGEMANN ROBERTDirector
|
GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004824 · form4.xml · derivative · entry 2 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,256.137 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:04 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004824 · form4.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,082.467 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 28.899 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.